Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Harvard Business School
Merck
McKesson
Boehringer Ingelheim

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

Benazepril hydrochloride - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for benazepril hydrochloride and what is the scope of patent protection?

Benazepril hydrochloride is the generic ingredient in four branded drugs marketed by Amneal Pharms, Ani Pharms Inc, Aurobindo Pharma, Casi Pharms Inc, Corepharma, Genpharm, Heritage Pharma, Mylan, Prinston Inc, Sun Pharm Inds Ltd, Teva, Zydus Pharms Usa, Us Pharms Holdings I, Apotex, Mylan Pharms Inc, and Sandoz, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride. Twenty-eight suppliers are listed for this compound.

Recent Clinical Trials for benazepril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Sun Yat-sen UniversityPhase 2/Phase 3
University of NebraskaPhase 4

See all benazepril hydrochloride clinical trials

Pharmacology for benazepril hydrochloride

US Patents and Regulatory Information for benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genpharm BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076476-004 Feb 11, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820-002 Feb 3, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE benazepril hydrochloride; hydrochlorothiazide TABLET;ORAL 076631-002 Feb 11, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 078212-003 May 22, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Teva BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076211-002 Feb 11, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for benazepril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-001 Jun 25, 1991   Start Trial   Start Trial
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-004 Jun 25, 1991   Start Trial   Start Trial
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-003 Jun 25, 1991   Start Trial   Start Trial
Us Pharms Holdings I LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-002 Jun 25, 1991   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Harvard Business School
Merck
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.